Organogenesis To Sponsor March 26 Webinar, “Taking Control of the Wound Healing Environment,” Featuring Dr. Alisha Oropallo
“Organogenesis is committed to the promotion of evidence-based care and the advancement of treatment approaches that improve patient health and wellbeing,” said
Webinar participants will learn how to address the factors that lead to wound chronicity and review steps for implementing interventions to help overcome obstacles to wound closure. In particular, the webinar will review specific strategies to encourage wound closure, including addressing infection, improving ischemia, changing metabolic conditions, and immunosuppression and radiation challenges.
A frequent lecturer on all aspects of wound management and treatment,
The Webinar comes as part of the WoundSource Practice Accelerator series, which is sponsored by PuraPly Antimicrobial® for the month of March. PuraPly AM is sold by Organogenesis.
This month’s sponsorship also includes the publication of a White Paper, “Non-Healing Wounds: What’s Happening in the Wound Bed?” The paper discusses the normal biological processes of wound healing and frequent contributors that may undermine the healing process, including infection or an elevated bioburden, reduced collagen production, and the failure of granulation tissue to grow or angiogenesis to occur. The White Paper may be downloaded here.
For webinar details, including registration information, please visit the WoundSource event registration page.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts for future events. Forward-looking statements may be identified by the use of words such as “will,” “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” “extend,” “continue,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are based on current expectations that are subject to known and unknown risks and uncertainties, which could cause actual results or outcomes to differ materially from expectations expressed or implied by such forward-looking statements. These factors include risks and uncertainties described in the Company’s filings with the
Press and Media Inquiries:
Susan Frodighsfrodigh@organo.com Investor Inquiries: Westwicke Partners Mike Piccinino, CFA OrganoIR@westwicke.com 443-213-0500
Source: Organogenesis Holdings Inc.